JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;133:81
© 2007 The American Association for Thoracic Surgery


General Thoracic Surgery

Discussion

Dr David R. Jones (Charlottesville, Va). Dr Bonde, that was a very nice presentation.

I have just 2 questions for you. Is the OGG1 downregulated in either acidic or basic conditions that are frequently associated with the development of Barrett’s epithelial changes or adenocarcinoma of the esophagus?

Dr Bonde. This particular model uses both gastric and duodenal reflux—that is, both acidic and alkaline reflux—to create this model. Therefore it was downregulated in terms of squamous cell cancers in both of them. However, we did not study the specific effect of the refluxate on the OGG1 expression in this current study.

Dr Jones. There are some data that reversing the continued insult of acid and bile into the esophagus will actually cause the Barrett’s changes to regress. Do you have any data on the regression of the changes in the 8-oxoG levels if you were to reverse this surgically created reflux model?

Dr Bonde. That is a very interesting question, and that is the one question that we would like to answer. It is known that the 8-oxoG concentration is higher in patients with esophageal cancer and in many cancers, particularly in the urine. We have mice models now that are specifically OGG1 knockout models, and to try this model in those mice will be the next plausible step to see whether there is a decrease in the incidence of Barrett’s in those mice. However, there are other ways of delivering this gene through gene therapy locally into the esophagus and seeing whether treatment with OGG1 really regresses the Barrett’s metaplasia in this model.

Dr Jones. Thank you. That was a very nice presentation.

Dr Bonde. Thank you.


Related Article

Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus
, , , , , , , and
J. Thorac. Cardiovasc. Surg. 133: 74-81. [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS